Strides Pharma Science (NSE:STAR) 3-Year EBITDA Growth Rate : -12.50% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science 3-Year EBITDA Growth Rate?

Strides Pharma Science's EBITDA per Share for the three months ended in Mar. 2024 was ₹17.36.

During the past 12 months, Strides Pharma Science's average EBITDA Per Share Growth Rate was 89.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Strides Pharma Science was 55.90% per year. The lowest was -26.40% per year. And the median was -7.40% per year.

Competitive Comparison of Strides Pharma Science's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strides Pharma Science's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's 3-Year EBITDA Growth Rate falls into.

Strides Pharma Science 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Strides Pharma Science (NSE:STAR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Strides Pharma Science 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science (NSE:STAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

532531:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Strides Pharma Science (NSE:STAR) Headlines

No Headlines